{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-181840","form_type":"8-K","ticker":"XOMA","cik":"0000791908","company_name":"XOMA Royalty Corp","filed_at":"2025-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.379022+00:00","generated_at":"2026-05-17T12:40:44.339753+00:00","sec_items":["2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"XOMA completes acquisition of Turnstone Biologics for $0.34 cash plus CVR per share","bullets":["XOMA accepted 17,192,002 shares (~74% of outstanding) at $0.34 plus one CVR per share.","Merger completed under Section 251(h) of DGCL; no stockholder vote held.","Outstanding shares not tendered converted to $0.34 and one CVR; options cancelled for no consideration.","CVR Agreement dated Aug 11, 2025, with Broadridge as rights agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-181840","json":"https://secwatch.observer/filing/0001193125-25-181840.json","markdown":"https://secwatch.observer/filing/0001193125-25-181840.md","text":"https://secwatch.observer/filing/0001193125-25-181840.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/791908/000119312525181840/0001193125-25-181840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791908/000119312525181840/d41745d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:40:44.339753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4b7d45fdeca99f61eccc049b1079bcc34667bf9","claim":"XOMA Royalty Corp completed an acquisition involving Turnstone Biologics Corp. for $0.34 per share plus one non-transferable contractual contingent value right (closed 2025-08-11).","evidence_excerpt":"2025, XOMA completed a tender offer to purchase all of Turnstone’s outstanding shares of common stock, par value $0.001 per share (the “ Shares ”), for a price per Share of (i) $0.34 (the “ Cash Amount ”), payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right (“ CVR ”), which","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312525181840/0001193125-25-181840-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Turnstone Biologics Corp."},{"label":"Consideration","value":"$0.34 per share plus one non-transferable contractual contingent value right"},{"label":"Closing","value":"2025-08-11"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}